IL6 and neoplasm: Thus, neither repeated transfer of splenic MDSCs from metastatic tumor-bearing mice nor overexpression of IL-6 was sufficient to confer on non-metastasizing EMT6 cancer cells a metastasizing capacity comparable to that of 4T1 breast cancer cells.